Lupin

Lupin

LUPIN

 ₹ 2,011.73
- ₹ 22.69
1.12%
Healthcare
 ₹ 0.00
(%)1D
Updated: 27 Mar 2025, 09:31:04 am IST
Stock Score
Open Price
 ₹ 2,005.50
Prev. Close
 ₹ 2,034.42
 ₹ 1,997.09
Day Low
 ₹ 2,021.00
Day High

 ₹ 1,642.25
52 Week Low
 ₹ 2,376.39
52 Week High

Quick Bite

Price To Earnings Ratio

47.89

Sector PE

63.34

PB Ratio

6.47

Sector PB

8.19

EPS

42.01

Dividend Yield

0.49

Today's Volume

657.358 K

5 Day Avg. Volume

623.914 K

PEG Ratio

0.14

Market Cap.

₹ 96,550.00 Cr.

News & Events

About Lupin

Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. It specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. It operates in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. It has a presence in the Cardiovascular, Diabetology, Asthama, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives and Nonsteroidal Anti Inflammatory Drug therapy segments and operates in the Anti-TB and Cephalosporins segments. Its generic formulations include Filgrastim, Pegfilgrastim, Etanercept and Albuterol. Its diabetes brands include Gibtulio, Ajaduo, Gibtulio Met, ONDERO and ONDERO MET. Its other brands include AntaGolin, RyChol and others. Its Huminsulin range of products includes Insulin Human.

Lupin Share Price

Lupin Limited is an Indian pharmaceutical company. The company manufactures, develops and markets a variety of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) worldwide. The company operates in the Cardiovascular, Diabetes, Asthma, Pediatric, CNS, Gastrointestinal, Anti-Infective and Non-Steroidal Anti-Inflammatory drug therapeutic segments and operates in the Anti-Tuberculosis and Cephalosporin segments. The company and its subsidiaries have manufacturing facilities in India, the United States, Mexico and Brazil, and trading and other ancillary and related activities also extend to global markets. Its complex generic portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its biosimilars include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim), and Etanercept.

Lupin FAQs

How to Buy Lupin Share?

up
To purchase Lupin shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lupin (ticker symbol: LUPIN) on the trading platform provided by your broker and purchase the shares.

What's Lupin share price today?

up
The stock price of Lupin as of 31 Mar 2025 is ₹2,011.73

What is the Market Cap of Lupin?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 31 Mar 2025, Lupin (ticker symbol: LUPIN) has a market capitalisation of approximately ₹9,65,50,00,00,000.00

What is the PE and PB ratio of Lupin?

up
Lupin Ltd's price-to-book ratio as of 31 Mar 2025 is 6.47, reflecting the market's valuation compared to its asset value. As of 31 Mar 2025, the trailing twelve months P/E (price-to-earnings) ratio is 47.89, indicating the market values the company at around ₹47.89 for every ₹1 of earnings

What is the 52 Week High and Low of Lupin Share?

up
Lupin Ltd (LUPIN) hit its 52-week high at ₹2,376.39, and its 52-week low at ₹1,642.25.
Begin your investment journey today
Login/Register
Start Now